» Articles » PMID: 29120067

Review of Patient Decision-making Factors and Attitudes Regarding Preimplantation Genetic Diagnosis

Overview
Journal Clin Genet
Specialty Genetics
Date 2017 Nov 10
PMID 29120067
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The increasing technical complexity and evolving options for repro-genetic testing have direct implications for information processing and decision making, yet the research among patients considering preimplantation genetic diagnosis (PGD) is narrowly focused. This review synthesizes the literature regarding patient PGD decision-making factors, and illuminates gaps for future research and clinical translation. Twenty-five articles met the inclusion criteria for evaluating experiences and attitudes of patients directly involved in PGD as an intervention or considering using PGD. Thirteen reports were focused exclusively on a specific disease or condition. Five themes emerged: (1) patients motivated by prospects of a healthy, genetic-variant-free child, (2) PGD requires a commitment of time, money, energy and emotions, (3) patients concerned about logistics and ethics of discarding embryos, (4) some patients feel sense of responsibility to use available technologies, and (5) PGD decisions are complex for individuals and couples. Patient research on PGD decision-making processes has very infrequently used validated instruments, and the data collected through both quantitative and qualitative designs have been inconsistent. Future research for improving clinical counseling is needed to fill many gaps remaining in the literature regarding this decision-making process, and suggestions are offered.

Citing Articles

Internet-Based Abnormal Chromosomal Diagnosis During Pregnancy Using a Noninvasive Innovative Approach to Detecting Chromosomal Abnormalities in the Fetus: Scoping Review.

Oyovwi M, Ohwin E, Rotu R, Olowe T JMIR Bioinform Biotechnol. 2024; 5:e58439.

PMID: 39412876 PMC: 11525087. DOI: 10.2196/58439.


Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant.

Onnekink A, Klatte D, van Hooft J, van den Berg S, van der Zwaan S, van Doorn R Fam Cancer. 2024; 23(3):255-265.

PMID: 38822936 PMC: 11255069. DOI: 10.1007/s10689-024-00401-3.


Preimplantation genetic testing for embryos predisposed to hereditary cancer: Possibilities and challenges.

Albujja M, Al-Ghedan M, Dakshnamoorthy L, Pla Victori J Cancer Pathog Ther. 2024; 2(1):1-14.

PMID: 38328708 PMC: 10846329. DOI: 10.1016/j.cpt.2023.05.002.


Addressing ethical issues related to prenatal diagnostic procedures.

Kaye D Matern Health Neonatol Perinatol. 2023; 9(1):1.

PMID: 36737803 PMC: 9896777. DOI: 10.1186/s40748-023-00146-4.


The effects of an online decision aid to support the reproductive decision-making process of genetically at risk couples-A pilot study.

Severijns Y, Heijmans M, de Die-Smulders C, Bijlsma E, Corsten-Janssen N, Joosten S J Genet Couns. 2022; 32(1):153-165.

PMID: 36056622 PMC: 10087273. DOI: 10.1002/jgc4.1631.